<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During embryonic development, variations in the composition of the extracellular matrix (ECM) macromolecules influence bone tissue differentiation </plain></SENT>
<SENT sid="1" pm="."><plain>We present novel findings on the in vitro phenotypic expression of periosteal fibroblasts obtained from patients affected by <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert's syndrome</z:e>, a rare craniofacial malformation, and the effects that interleukins (ILs) induce on the phenotype </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> fibroblasts synthesized greater quantities of <z:chebi fb="0" ids="18085">glycosaminoglycans</z:chebi> (GAGs) and intracellular type I collagen, and also produced more type III collagen and fibronectin </plain></SENT>
<SENT sid="3" pm="."><plain>The amount of <z:chebi fb="1" ids="16336">hyaluronic acid</z:chebi> (HA) secreted by <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> fibroblasts was much higher than that secreted by <z:mpath ids='MPATH_458'>normal</z:mpath> fibroblasts, but, as the absolute values of <z:chebi fb="0" ids="24500">heparan</z:chebi> <z:chebi fb="100" ids="16189">sulphate</z:chebi> (HS), <z:chebi fb="0" ids="37397">chondroitin sulphate</z:chebi> (CS) and dermatan <z:chebi fb="100" ids="16189">sulphate</z:chebi> (DS) also rose in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> media, the HA-sulphated GAG ratio was similar in the media obtained from both populations </plain></SENT>
<SENT sid="4" pm="."><plain>Both ILs triggered elevations of HA in <z:mpath ids='MPATH_458'>normal</z:mpath> cells, although relative percentage secretion remained unaltered, but significantly reduced HA secretion by <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>IL-1 significantly increased CS in <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> media, whereas IL-6 enhanced HS and DS in media of both populations </plain></SENT>
<SENT sid="6" pm="."><plain>HA-sulphated GAG ratio decreased in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> media after IL treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Both ILs boosted fibronectin production by <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> fibroblasts, whereas IL-1 increased type III but not type I collagen </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, these data demonstrate that the synthesis and secretion of ECM macromolecules are markedly altered in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> fibroblasts </plain></SENT>
<SENT sid="9" pm="."><plain>The fact that treatment with ILs further modifies the <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> phenotype suggests that ILs may be implicated in the pathophysiology of the malformations during skull morphogenesis </plain></SENT>
</text></document>